Abstract
Multiple Endocrine Neoplasia type 2 (MEN2) is an autosomal dominant genetic disorder caused by germline mutations in the RET gene. Access to RET gene testing made it possible to improve the diagnosis and precision in the management of patients with MEN2. However, there are no studies that have critically evaluated the evolution and other factors involved in the implementation of the RET g…